FibroBiologics, Inc. Common Stock

FBLGNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
0.85 USD
↗ 0.03 (3.77%)🟢LIVE (AS OF 09:58 AM EDT)
🟢Market: OPEN

FBLG is currently priced at $0.85. FBLG shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, FBLG appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Aug 4, 2026.

Open?$0.85
High?$0.88
Low?$0.81
Prev. Close?$0.82
Volume?41.9K
Avg. Volume?139.8K
VWAP?$0.85
Rel. Volume?0.30x
Bid / Ask
Bid?$0.73 × 100
Ask?$0.99 × 100
Spread?$0.26
Midpoint?$0.86
Valuation & Ratios
Market Cap?5.0M
Shares Out?6.7M
Float?4.6M
Float %?87.4%
P/E Ratio?N/A
P/B Ratio?1.08
EPS?-$2.98
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
Themes
Biotech - Drug Development›Rare Disease TherapeuticsLongevity & Aging›Age-Related Therapeutics
Employees
15
Market Cap
4.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fibrobiologics.com
Listed
2024-01-31
Address
9350 KIRBY DRIVE
HOUSTON, TX 77054
Phone: 281-671-5150
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
100
Piotroski F-Score?0/9Weak
Altman Z-Score?-16.68Distress
Confidence?40%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.56%Low
Short Interest?70.8K
Days to Cover?1.2
Free Float4.6M
Avg Daily Volume59.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?2.64Strong
Quick Ratio?2.64Strong
Cash Ratio?1.59Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
1.08CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-391.3%WEAK▾
ROA?
S&P
3
-228.8%WEAK▾
Cash Flow & Enterprise
FCF?$-14796000
Enterprise Value?$1.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist